Bipartisan Hemp Relief Bill Set for Congress to Counter Looming Federal Recriminalization

A bipartisan push to safeguard the U.S. hemp industry is gaining momentum as Senators Rand Paul (R-KY) and Amy Klobuchar (D-MN) prepare to introduce legislation aimed at averting the federal recriminalization of hemp-derived THC products. The move comes in response to new federal provisions, signed into law late last year by former President Donald Trump, which will redefine legal hemp and severely restrict THC content in products starting in November. Industry advocates and lawmakers warn that this change could devastate a sector that has flourished since the 2018 Farm Bill first legalized hemp with less than 0.3 percent delta-9 THC

Speaking during an online town hall this week, Sen. Paul emphasized the urgency of the situation. 'I lament the government’s trying to destroy this industry now, but I’m doing everything I can and working across the aisle with a Democrat senator to try to say that if your state has decided to regulate hemp, then the state law would supersede the federal law, which is kind of really the way it’d be ought to be,' Paul said. He highlighted Kentucky's success with hemp, noting its economic benefits for farmers and the rise of new startup companies in the state

The forthcoming Paul-Klobuchar bill is expected to allow states to opt out of the impending federal THC restrictions and continue interstate commerce of hemp products between consenting states. Paul explained that Klobuchar's role on the Senate Agriculture Committee could help attach their proposal to the upcoming Farm Bill, increasing its chances of passage. 'Our hope is that she can get a vote in committee to try to attach this to the Farm Bill,' Paul stated. The bill text has yet to be released, but sources indicate it is designed to give states the final say over hemp regulation within their borders

Farmers and businesses are facing a period of significant uncertainty as the November deadline approaches. 'It’s difficult for those in business right now, because it’s a crop, it has to be planted, and if it’s going to be made illegal in November, farmers are wondering whether they should plant it this year,' Paul said. Other legislative efforts to delay or prevent the scheduled crackdown on hemp THC products have so far failed to gain traction in Congress, leaving the industry in limbo as planting season begins

Meanwhile, the federal government is taking other steps that affect the hemp and cannabis landscape. The Centers for Medicare & Medicaid Services recently launched a program to cover up to $500 in hemp-derived products for eligible Medicare patients, including some products with THC content. This policy has drawn legal challenges from anti-marijuana organizations, while the FDA has issued guidance clarifying it will not interfere with the Medicare hemp product coverage. Major retailers like Target are also expanding their offerings of hemp-derived THC beverages, signaling ongoing consumer demand despite regulatory uncertainty

For the global cannabis industry, this bipartisan legislative initiative represents a pivotal moment. If successful, it could preserve the viability of the U.S. hemp sector and set a precedent for state-led regulation in the face of shifting federal policy. OG Lab will be monitoring how Congress responds, as the outcome could reverberate across markets and influence future cannabis and hemp reform efforts nationwide